McGregor CG, Adams A, Sadler R, Arancibia-Carcamo CV, et al. Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic. Gut 2021;70:2398-2400.
PMID: 33579788